Plain-English translation of NCT07674069 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new portable device called the World Sight Foundation Field Machine (WSFFM) to see how well it can detect moderate to severe vision loss in people with glaucoma. The device will be compared to the Humphrey Visual Field Analyser, which is the standard test used in eye clinics today. The researchers want to understand whether this new portable device could be useful for detecting advanced vision loss in glaucoma patients.
Doctors need tools that can reliably detect when glaucoma has caused moderate to severe vision loss, especially in settings where the standard equipment may not be available. This trial is exploring whether the new portable device could fill that gap and make glaucoma screening more accessible.
You likely qualify if…
You likely don't qualify if…
If you choose to participate, you will have both visual field tests done on one of your eyes during a single clinic visit — no extra appointments needed. One eye will be randomly selected to be tested by both the new portable device and the standard machine, one after the other. The entire process happens as part of your regular clinic visit, and there is no follow-up required after that day.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
United Kingdom